ENTRY       D10541                      Drug
NAME        Aducanumab (USAN);
            Aducanumab (genetical recombination) (JAN);
            Aduhelm (TN)
PRODUCT     ADUHELM (Biogen)
FORMULA     C6472H10028N1740O2014S46
EXACT_MASS  145820.2915
MOL_WEIGHT  145910.3123
SEQUENCE    (Heavy chain)
            XVQLVESGGG VVQPGRSLRL SCAASGFAFS SYGMHWVRQA PGKGLEWVAV IWFDGTKKYY
            TDSVKGRFTI SRDNSKNTLY LQMNTLRAED TAVYYCARDR GIGARRGPYY MDVWGKGTTV
            TVSSASTKGP SVFPLAPSSK STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV
            LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK RVEPKSCDKT HTCPPCPAPE
            LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE
            EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP
            SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD
            KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSIS SYLNWYQQKP GKAPKLLIYA ASSLQSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ SYSTPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H151-H207, H227-L214, H233-H'233, H236-H'236, H268-H328, H374-H432, H'22-H'96, H'151-H'207, H'227-L'214, H'268-H'328, H'374-H'432, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
CLASS       Neuropsychiatric agent
             DG01968  Antidementia agent
REMARK      ATC code: N06DX03
            Product: D10541<US>
EFFICACY    Dementia therapeutic agent
  DISEASE   Alzheimer's disease [DS:H00056]
  TYPE      Monoclonal antibody
COMMENT     Treatment of Alzheimers disease
TARGET      Amyloid beta [CPD:C16514 C16515]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06D ANTI-DEMENTIA DRUGS
                N06DX Other anti-dementia drugs
                 N06DX03 Aducanumab
                  D10541  Aducanumab (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antidementia Agents
              Antidementia Agents, Other
               Aducanumab
                D10541  Aducanumab (USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01968  Antidementia agent
               D10541  Aducanumab
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01968  Antidementia agent
               D10541  Aducanumab
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10541
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10541
DBLINKS     CAS: 1384260-65-4
            PubChem: 254741503
///
